First published:27 February 2020OBJECTIVE: To review medication-related criteria within validated frailty tools. METHODS: Narrative review of validated frailty assessment tools. Frailty tools were identified from recently published reviews; each tool was reviewed to determine whether any medication-related criteria were included and how these criteria contributed to the scoring/assessment of frailty. RESULTS: Eight out of 16 validated frailty tools included medication-related criteria. The majority of criteria were a numerical cut-off of number of medications taken; however, the specific cut-off was not consistent. CONCLUSION: Inclusion of medication-related criteria in frailty tools is highly variable. Future research is required to determ...
Background: Many operationalisations of frailty exclude psychosocial factors, despite considerable r...
Background: Frailty and adverse drug effects are linked in the fact that polypharmacy is correlated ...
Introduction: The role of frailty in postmarketing drug safety is increasingly acknowledged. Few Eur...
Background: Frailty is a common but complex problem in older adults. Frailty assessment using routin...
Objectives: Frailty is an increasingly common health condition and is seen more often due to the age...
This study systematically reviews the published literature regarding inappropriate prescribing in fr...
Older populations are more likely to have multiple co-morbid diseases that require multiple treatmen...
Introduction. Frailty screening and assessment are a fundamental issue in Public Health in order to ...
This ‘Points to Consider’ document provides a menu of validated and therefore recommended instrument...
Frailty measurement in primary care and at transitions of care is needed to enable timely identifica...
Contains fulltext : 97192.pdf (publisher's version ) (Closed access)Frailty is one...
A standardized characterization of frailty is potentially useful for risk stratification and to impr...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Background: Frailty, a very important complication of increasing age, is a well-recognised concept a...
Background Frailty and adverse drug effects are linked in the fact that polypharmacy is correlated w...
Background: Many operationalisations of frailty exclude psychosocial factors, despite considerable r...
Background: Frailty and adverse drug effects are linked in the fact that polypharmacy is correlated ...
Introduction: The role of frailty in postmarketing drug safety is increasingly acknowledged. Few Eur...
Background: Frailty is a common but complex problem in older adults. Frailty assessment using routin...
Objectives: Frailty is an increasingly common health condition and is seen more often due to the age...
This study systematically reviews the published literature regarding inappropriate prescribing in fr...
Older populations are more likely to have multiple co-morbid diseases that require multiple treatmen...
Introduction. Frailty screening and assessment are a fundamental issue in Public Health in order to ...
This ‘Points to Consider’ document provides a menu of validated and therefore recommended instrument...
Frailty measurement in primary care and at transitions of care is needed to enable timely identifica...
Contains fulltext : 97192.pdf (publisher's version ) (Closed access)Frailty is one...
A standardized characterization of frailty is potentially useful for risk stratification and to impr...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Background: Frailty, a very important complication of increasing age, is a well-recognised concept a...
Background Frailty and adverse drug effects are linked in the fact that polypharmacy is correlated w...
Background: Many operationalisations of frailty exclude psychosocial factors, despite considerable r...
Background: Frailty and adverse drug effects are linked in the fact that polypharmacy is correlated ...
Introduction: The role of frailty in postmarketing drug safety is increasingly acknowledged. Few Eur...